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Background: The understanding of the mechanisms of immunity in malaria is crucial for the rational development
of interventions such as vaccines. During blood stage infection, the spleen is considered to play critical roles in
both immunity and immunopathology of Plasmodium falciparum infections.
Methods: Saimiri sciureus monkeys were inoculated with blood stages of P. falciparum (FUP strain) and spleens
removed during acute disease (days 7 and 13 of infection) and during convalescence (15 days after start of
chloroquine treatment). Cytokine (IFNγ, TNFα, IL2, IL6, IL10, and IL12) responses of splenocytes stimulated with
P. falciparum-parasitized red blood cells were assessed by real-time PCR using specific Saimiri primers, and
histological changes were evaluated using haematoxylin-eosin and Giemsa-stained slides.
Results: Early during infection (day 7, 1-2% parasitaemia), spleens showed disruption of germinal centre architecture
with heavy B-cell activation (centroblasts), and splenocytes showed increased expression of IFNγ, IL6 and IL12 upon
in vitro stimuli by P. falciparum-parasitized red blood cells (pRBC). Conversely, 15 days after treatment of blood stage
infection with chloroquine, splenocytes showed spontaneous in vitro expression of TNFα, IL2, IL6, IL10, and IL12, but
not IFNγ, and stimulation with P. falciparum pRBC blocked the expression of all these cytokines. During the acute phase
of infection, splenic disarray with disorganized germinal centres was observed. During convalescence, spleens of the
chloroquine-treated animals showed white pulp hyperplasia with extensive lymphocyte activation and persistency
of heavily haemozoin-laden macrophages throughout the red pulp.
Conclusions: Inability to eliminate haemozoin is likely involved in the persistent lymphocyte activation and in the
anergic responses of Saimiri splenocytes to P. falciparum pRBC, with important negative impact in immune
responses and implications for the design of malaria vaccine.
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Malaria infections induce complex and not still completely
understood immune responses. Individuals continuously
exposed to infection in areas of intense malaria transmis-
sion take many years to develop effective clinical and para-
sitological immunity, although adults may develop effective
responses faster than children [1-4]. It appears, therefore,
that immune responses to sporozoite, liver and blood stages
of Plasmodium as well to heterologous antigens, such as
vaccines against immuno-preventable diseases, are defective
[5]. Despite being of limited efficacy against the parasite or
its toxic products, immune responses to malaria infections
can be deleterious, causing immunopathology, which is be-
lieved to play a role in complications such as cerebral mal-
aria [6,7]. The limited knowledge of the mechanisms of
immunity and pathogenesis in malaria creates difficulties
for the development of rational preventative and thera-
peutic interventions, such as vaccines [8].
The neotropical monkeys Aotus and Saimiri are the non-
human primates recommended by the World Health
Organization for experimental malaria research [9] and rep-
resent the closest animal models to the human infection
owing to their unique ability to develop a reproducible
parasitaemia when inoculated with blood stages of Plasmo-
dium falciparum or Plasmodium vivax. These features
make them particularly useful in pre-clinical trials of poten-
tial malaria vaccines, as well in studies of pathogenesis of
the disease [10-13]. However, studies with these animals are
often limited by the lack of specific reagents and molecular
tools allowing, for instance, reliable evaluation of immune
responses. The partial nucleotide sequence of 13 cytokine
genes of Saimiri sciureus and Aotus infulatus had been pre-
viously described [14]. In the present study primers specific
for the Saimiri cytokines IFNγ, TNFα, IL2, IL6, IL10, and
IL12 were designed and used to study splenic cellular re-
sponses during and after blood stage P. falciparum infec-
tion in S. sciureus monkeys.
Methods
Animals
Saimiri sciureus monkeys were bred and housed at the
National Primate Centre, Secretaria de Vigilância em Saúde
(SVS, Health Surveillance Secretary) in Belém, and at the
Department of Primatology of the Centro de Criação de
Animais de Laboratório (CECAL, Centre for Breeding of
Laboratory Animals), Fiocruz, Rio de Janeiro, Brazil. All an-
imals used in this study were adults born in captivity. The
experimental protocols were reviewed and approved by the
local Ethical Committees for Animal Use.
Design and validation of specific primers
The primers for cytokine amplification by quantitative real
time PCR (qRT-PCR) were designed using as template the
previously described conserved genomic sequences betweenS. sciureus and A. infulatus [14]. The primers used were as
follows: IFNγ: 5′-TTTCTTAAACATTTTGAGGACT
TGGA-3′ (sense) and 5′-AAGGAGATAATCTGGCTCTG-
CATT-3′ (antisense); TNFα: 5′-CTCTTCTGCCTGCTGC
ACTTC-3′ (sense) and 5′-AAGTCCCTGGAGGACTGCT
CTT-3′ (antisense); IL2: 5′-GTGCACCTACTTCAAGTT
CTACAAAGA-3′ (sense) and 5′-CATCTGTAAGTCCAG-
CAGTAAATGC-3′ (antisense); IL6: 5′-TGGCAGAAAAA-
GATGGATGCT-3′ (sense) and 5′-CTCCAAAAGACC
AGTGGTGATTT-3′ (antisense); IL10: 5′-GCAGTGGCG-
CAGGTGAA-3′ (sense) and 5′-GGCTTTGTAGACGC
CTTTCTCTT-3′ (antisense); IL12 (IL12p40): 5′-AGGTCT-
TAGGCTCTGGCAAAAA-3′ (sense) and 5′-TGGCCAG-
CATCTCCAACTCT-3′ (antisense); and β-actin (internal
control of reaction): 5′-CACCACACCTTCTACAATGAG-
3′ (sense) and 5′-GTCTCAAACATGATCTGGGTC-3′
(antisense). The primers above were designed based on the
following Saimiri and Aotus GenBank sequences: IFNγ:
DQ989367 (Saimiri) and DQ989366 (Aotus); TNFα:
DQ989365 (Saimiri) and DQ989364 (Aotus); IL2:
DQ989369 (Saimiri) and DQ989368 (Aotus); IL6:
DQ985387 (Saimiri) and DQ985386 (Aotus); IL10:
DQ989357 (Saimiri); IL12p40: DQ989358 (Saimiri) and
DQ989359 (Aotus).
To validate the primers, blood (4 mL) was withdrawn
from the femoral vein of healthy adult S. sciureus monkeys
into EDTA-containing Vacutainer tubes. Peripheral blood
mononuclear cells (PBMC) were separated by density gra-
dient centrifugation using Ficoll-Hypaque 1077 (Sigma, St
Louis, USA) and washed three times with RPMI (Sigma).
PBMC (2×106 cells/well) were cultured in RPMI 1640
medium supplemented with 10% foetal calf serum with or
without 500 ng/mL ionomycin and 50 ng/mL phorbol 12-
myristate 13-acetate (PMA) (all from Sigma). The plates
were incubated for two, four, six, eight, 12, and 18 hours
at 37°C in 5% CO2. At each time point, cells were har-
vested and lysed for RNA extraction (see below).
Purification of total RNA and cDNA synthesis
Total RNA was isolated from cells using RNeasy kit
(Qiagen) to a final volume of 50 mL according to the man-
ufacturer’s protocol. Then, the RNA was concentrated
using YM-30 ultracel Microcon (Millipore), resuspended
to 10 mL and transcribed to cDNA using High-Capacity
kit (Applied Biosystems). Briefly, the reaction contained
10 mL total RNA (initial amount of 1 mg), 1X RT Buffer,
1X dNTP mix (100 mM), 1X RT Random Primers, 2.5U
MultiScribeTM Reverse Transcriptase and 3.2 ml nuclease-
free water in a total volume of 20 mL. The reaction mix-
ture was incubated at 25°C for 10 min, followed by heating
at 37°C for 120 min and at 85°C for 5 sec, concentrated
with YM-30 ultracel Microcon (Millipore), and resus-
pended for final volume of 500 mL, aliquoted (2 ng/mL)
and maintained at −20°C.
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The qRT-PCR was carried out in a 20-mL final volume
containing: i) 4 mL H2O; ii) 1 mL forward and reverse
primer mix (4 pmol/mL); iii) 5 mL cDNA; and, iv)
10 mL SYBR Green Master Mix (Applied Biosystems).
The reaction contained three stages: i) 50°C for 2 min to
activate the Uracil-DNA N-glycosylase (UNG) enzyme;
ii) 95°C for 10 min to activate the TaqGold enzyme; and,
iii) 45 cycles at 95°C for 15 sec, at 60°C for 20 sec and at
72°C for 1 min. Results were expressed in fold-change in
relation to the calibrator sample (extracted RNA without
mitogen stimulation).
Plasmodium falciparum infection and follow up
Nine intact (non-splenectomized) S. sciureus monkeys
were used in the infection experiments (six infected and
three controls). Six monkeys were injected intravenously
with 5x107 P. falciparum (FUP)-pRBC with a predomin-
ance of ring and young trophozoite stages obtained from
an infected splenectomized S. sciureus. Parasitaemia was
followed up daily by examination of Giemsa-stained thin
smears of blood obtained from the footpad. Two in-
fected Saimiri monkeys were treated with chloroquine
(three daily doses of 10 mg/kg) on day (d) 7 (parasit-
aemia of 1-2%) and four Saimiri monkeys were treated
on d13 of infection (parasitaemia over 10%). Monkeys
were subjected to splenectomy right before chloroquine
treatment (two monkeys on d7 and two monkeys on
d13) or 15 days after the start of chloroquine treatment
(two monkeys on d28).
Saimiri splenocytes
Plasmodium falciparum-infected Saimiri monkeys were
subjected to splenectomy at the time points described
above (d7, d13 and d28). One uninfected control Saimiri
monkey was also splenectomized at each day (d7, d13
and d28, total of three control animals). Splenectomy
was performed under anaesthesia with ketamine
(150 mg/kg) plus xylazine (10 mg/kg), in an aseptic sur-
gical room by a trained veterinarian. After spleen re-
moval and vascular resections, the wound was sutured
and the animals allowed to recover under close supervi-
sion of trained staff. After recovery from surgery, mon-
keys were treated with chloroquine. Right after removal,
a piece of the spleen was immersed and kept in formalin
for histological analysis and a second piece was condi-
tioned in sterile RPMI 1640 medium supplemented with
10% foetal calf serum and handled in a laminar flow
cabinet. Spleens were gently fragmented between
glass microscope slides and the splenocyte suspension
was layered on Ficoll-hypaque 1077 (Sigma) gradient.
Splenocytes were cultured in vitro under antigenic
stimulation with P. falciparum-parasitized red blood
cells (pRBC) (see below).In vitro Plasmodium falciparum culture
Plasmodium falciparum (FCR3 strain) was maintained
in vitro in continuous culture according to the method
described by Trager and Jensen [15] under an atmos-
phere of 5% CO2, 5% O2 and 90% N2 (White Martins)
using O+ human RBC in RPMI-1640 medium (Sigma)
supplemented with 25 mM Hepes (Sigma), 0.2% glucose
(Sigma), 23 mM sodium bicarbonate (Sigma) and
40 mg/L gentamycin (Gibco).
In vitro splenocyte stimulation
Freshly isolated splenocytes (2×106 cells/well) were lay-
ered in 24-well tissue culture plates (Corning, NY, USA)
in HEPES-buffered 1640 RPMI supplemented with 10%
heat-inactivated foetal calf serum (Sigma) and co-
cultured with asynchronous P. falciparum-pRBC or nor-
mal, uninfected RBC, at a proportion of 20 pRBC
(or RBC) per splenocyte. Cells were incubated at 37°C
for six hours in an atmosphere of 5% CO2. After culture,
cells were harvested and lysed for RNA extraction,
cDNA synthesis and qRT-PCR as described above.
Results were expressed in fold-change in relation
to non-stimulated splenocytes from control uninfected
monkeys.
Histological analysis
Spleen fragments were fixed in Carson’s modified
Millonig’s phosphate-buffered formalin, pH 7.4 [16]. The
specimens were processed with increasing ethanol con-
centrations (70, 95 and 100%, for one hour each), cleared
in xylene (two hours), and paraffin embedded. Sections
of 5 μm thickness were dewaxed with xylene (three
times), hydrated with ethanol (three times each in 100,
95, 70, and 50%) and stained with Lennert’s Giemsa
[17,18]. Slides were analysed by bright-field microscopy
(Zeiss Axiovert 200 M) and images captured with a
digital camera (Zeiss Axiocam HRc) and processed with
the ZoomBrowser EX software (Canon).
Statistical analysis
All statistical analyses were performed using a statistical
software package (Prism 5.0, Graphpad). A two-way ana-
lysis of variance (ANOVA) test with Bonferroni post-hoc
analysis was used to determine the significance of differ-
ences in cytokine expression on d7 and 28. A p value <0.05
was considered significant.
Results
Validation of Saimiri cytokine primers for qRT-PCR
The partial sequences of 13 cytokine genes from S. sciur-
eus and A. infulatus had been previously described [14].
Based on these sequences, primers for qRT-PCR were
designed for IFNγ, TNFα, IL2, IL6, IL10 and IL12, as
well as for the housekeeping gene β-actin, used to
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corresponding cDNA fragment obtained from Saimiri
PBMC stimulated in vitro with mitogens (ionomicyn-
PMA) with satisfactory efficiency and specificity
(Figure 1A). An assessment of the kinetics of gene
expression upon mitogenic stimulation showed in-
creased cytokine mRNA expression in relation to pre-
stimulation (time zero) at all time points tested (two to
18 hours), with the highest expression levels observed at
six hours for most cytokines tested (Figure 1B).
Cytokine expression in Saimiri splenocytes during and
after Plasmodium falciparum infection
Six adult S. sciureus monkeys were inoculated with 5×107
P. falciparum-FUP pRBC. All monkeys became parasitae-
mic, with parasitaemias in the range of 1-2% on d6
(Figure 2). Two animals were splenectomized on d7 and
then treated with chloroquine. Parasitaemia continued to
grow in the remaining four animals and all were treated
on d13. Two of these four monkeys were splenectomized
on d13 and the other two on d28 post-infection (15 days
after starting chloroquine treatment).
Splenocytes of P. falciparum-infected monkeys stimu-
lated with P. falciparum-pRBCs showed increased expres-
sion levels of IFNγ, IL6 and IL12 on d7 of infection
(Figure 3). IFNγ expression, in particular, was increased
nearly 100-fold. In addition, IFN-γ was the only cytokine
whose expression was increased in non-stimulated spleno-
cytes from P. falciparum-infected monkeys. The pattern
of cytokine expression was quite different 15 days after the
infection was cured (d28 post-inoculation). At this point,
stimulation of splenocytes with P. falciparum pRBC was
unable to induce expression of any of the cytokines stud-
ied (Figure 3). However, and interestingly, non-stimulated
splenocytes of P. falciparum-infected Saimiri monkeys
showed increased expression of TNFα, IL2, IL6, IL10, and
IL12 after six hours of unstimulated in vitro culture.
Considering the spontaneous increased expression in non-
stimulated cells, it can be concluded therefore that adding
P. falciparum pRBC actually inhibited expression of these
cytokines. IFNγ, the only cytokine with increased expres-
sion in non-stimulated cells on d7, showed no change in
expression on d28.
Histology
Spleens of non-infected control Saimiri monkeys showed
quiescent T-cell zones, without immunoblasts (Figure 4A)
and mostly resting B-cell follicles. The B follicles com-
monly presented a central area of weakly stained cells sur-
rounded by small lymphocytes (Figure 4B, C) although a
few germinal centres phase I and eventually phase II were
observed. Rare mitoses were observed and there were
well-defined limits between the red and white pulps
(Figure 4A). The red pulp presented mostly cells withweakly stained nuclei, especially near the outer capsule.
Interestingly, several clusters of weakly stained cells, sug-
gestive of macrophages, were observed in the spleen of
uninfected Saimiri monkeys (Figure 4A, C).
On d7 of infection, malaria pigment was observed in
pRBCs throughout an engorged red pulp (Figure 4D).
Several immunoblasts were found in the T-cell zone. The
B-cell follicles showed penetration by RBCs, and limits be-
tween the red and white pulps were blurred (Figure 4E).
Large cells with weakly stained nuclei suggestive of cen-
troblasts were widespread, and mitosis and apoptosis foci
were also abundant (Figure 4F). The characteristic phases
of germinal centre development were not observed, and
follicles presented typically a wide area of light-stained nu-
clei cells surrounded by small lymphocytes (Figure 4E).
On d13 – the day of peak parasitaemia, just before
chloroquine treatment – both red and white pulps were en-
larged in relation to controls and d7 of infection and
phagocytes were heavily laden with pigment (Figure 5A, B).
Follicles showed penetrating RBCs and limits between red
and white pulp were blurred (Figure 5A, C). Follicles were
interspersed with cells of different morphology, showing
phagocytes with malaria pigment, centroblasts and mainly
small lymphocytes in the periphery (Figure 5D). Strings of
cells suggestive of plasmacytogenesis cords [19] were ob-
served near the T-cell zone (Figure 5B).
On d28 (15 days after chloroquine treatment) the red
pulp phagocytes were heavily laden with malaria pigment
(Figure 5E, F). The distribution of haemozoin-containing
phagocytes was better defined in relation to d13, with cells
distributed in the red pulp surrounding the follicles, and
with individual cells containing more compacted, less gran-
ulous pigment (Figure 5E, F). This clear-cut distribution of
haemozoin-containing phagocytes in the red pulp without
penetrating the follicles indicated a better structured
spleen, likely recovering from the architecture disarray
peaking on d13. Despite animals had been treated for
15 days and clear of parasites for over ten days, the follicles
were further enlarged in relation to d13, with large follicles
touching each other with little red pulp in between
(Figure 5E) and showed mostly activated cells (Figure 5F).
Discussion
In this study, primers for quantitative real time PCR for
Saimiri IFNγ, TNFα, IL2, IL6, IL10, and IL12 were vali-
dated and used in a study of splenic responses in S. sciur-
eus during blood infection by P. falciparum. All primers
were shown to amplify their respective target sequences
with efficiency and specificity. Although some studies took
advantage of human sequences to evaluate cytokine ex-
pression in Saimiri and Aotus [20,21], the availability of
primers specifically designed for these species brings more
confidence for reliable amplification of the target se-
quences. Importantly, because each of the described
Figure 1 (See legend on next page.)
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Figure 1 Efficiency and kinetics of Saimiri sciureus cytokine cDNA amplification. (A) Efficiency of cytokine (IFNγ, IL2, IL6, IL10, IL12, TNFα)
cDNA amplification by real-time PCR using pair of primers specifically designed for Saimiri sciureus sequences. The Figure shows the average Ct values
after cytokine amplification using serial five-fold dilutions of cDNA from Saimiri peripheral blood mononuclear leukocytes stimulated with ionomycin-
PMA. (B) Kinetics of cytokine (IFNγ, IL2, IL6, IL10, IL12, TNFα) cDNA amplification by real-time PCR following in vitro mitogen stimulation. Peripheral
blood mononuclear leukocytes from non-infected Saimiri were stimulated in vitro with ionomycin-PMA and mRNA amplification was determined at
various timepoints. Results are shown as fold increases in cytokine expression in relation to unstimulated leukocytes.
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Saimiri and Aotus, they can be used to amplify the target
sequences from material derived from both species.
Most malaria vaccine studies in these non-human pri-
mates use splenectomized animals to ensure consistent
and reproducible parasitaemias [10-13,22-27]. Indeed,
P. falciparum infections in intact, non-splenectomized
Saimiri monkeys can be unsuccessful or produce short-
term, low-grade, variable parasitaemias. However, the
present study, as well as previous reports, show that a con-
sistent and substantial parasitaemia can be achieved in
non-splenectomized animals using strains better adapted
through repeated passages in intact animals. Contamin
and colleagues [28] used a P. falciparum clone derived
from the FUP strain to induce blood stage infection in
S. sciureus with a relatively low inoculum of 1x106 pRBC.
They reported that the course of infection was reprodu-
cible, with similar lengths of pre-patent and patent periods
and all animals were able to control and cure their parasit-
aemia without the need for treatment. The peak parasit-
aemia, however, varied between animals, ranging from 2
to 10%. Horii and colleagues immunized S. sciureus with a
recombinant protein derived from the P. falciparum serine
repeat antigen 5 and challenged them with a high inoculum
of 1×109 pRBC of the P. falciparum Indochina-1/CDC
strain [29]. Non-immunized control animals developed aFigure 2 Course of parasitaemia. Six Saimiri sciureus monkeys
were inoculated with 5×107 P. falciparum parasitized red blood cells.
Two monkeys were splenectomized and treated with chloroquine
at d7 (solid lines). The four remaining monkeys were treated with
chloroquine at d13, and two of them were splenectomized on
day 13 (dashed lines) and two on day 28 (dotted lines).parasitaemia over 10% with a short pre-patent period and
were also able to self-cure without the need for treatment.
In the present study, a consistent parasitaemia was induced
in non-splenectomized animals using an inoculum of
5×107 pRBC of the P. falciparum uncloned FUP strain. The
spleen is a key organ in immune response against malaria
and an important site of parasite killing by macrophages
[30-36]. In addition, splenectomy makes the model more
distant of the human malaria characteristics. Therefore, the
use of intact animals, besides making the model closer and
more relevant for human malaria, provides a unique oppor-
tunity to study splenic immune responses during falcip-
arum malaria.
The profile of cytokine expression of splenocytes upon
pRBC stimulation in vitro showed interesting features.
First, during the acute phase of infection, on d7, when
parasitaemia is growing but relatively low, IFNγ was the
cytokine with the highest expression levels, followed by
IL6 and IL12. On the other hand, IL2, IL10 and TNFα
showed no changes in expression in relation to unstimu-
lated cells from uninfected control monkeys. This pattern
indicates that blood stage P. falciparum induces a potent
Th1-skewed response in S. sciureus. In humans, cytokines
such as IFNγ and IL12 enables the host to effectively man-
age the exponential growth of Plasmodium until an effect-
ive adaptive response is established [37]. In addition, a
pro-inflammatory type of response is associated with more
rapid control of parasite growth but also with the develop-
ment of clinical symptoms [38]. In mice, blood stage plas-
modial infections also usually induce an early Th1-type
response. A switch later to a predominant Th2 response is
associated with acquisition of immunity, while the persist-
ence of the Th1 response may generate immunopathology
[39]. The evaluation of Th2 responses in this study was
limited by the availability of primers for IL10 only. It is im-
portant to develop primers for IL4, IL13 and TGFβ, for
example, and also other pro-inflammatory and regulatory
cytokines, such as IL17 and IL18, for better and more
complete assessment of the cytokine expression profile. It
is known that the expression of anti-inflammatory cyto-
kines such as IL4 and IL10 is critical in the control of an-
aemia and severe malaria and the expression of these
cytokines is associated with biochemical patterns of iron
deficiency in infected children [40]. Saimiri and Aotus are
vulnerable to one of the most serious complications of
malaria, severe anaemia [10-13] and, therefore, these
Figure 3 Cytokine expression by real-time PCR in Saimiri sciureus splenocytes. Animals were splenectomized at d7 (two monkeys, rising
parasitaemia) and d28 (two monkeys, 15 days after start of chloroquine therapy) post-inoculation with 5×107 P. falciparum pRBC. Splenocytes were
stimulated in vitro with P. falciparum pRBC or culture medium. Fold increases in cytokine expression were calculated in relation to unstimulated
splenocytes from two uninfected control Saimiri monkeys. *: p <0.05; **: p <0.01; ***: p <0.001 (two-way ANOVA with Bonferroni post test).
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in the context of this malaria complication.
The elevated levels of IFNγ, IL6 and IL12 on d7 of infec-
tion were mirrored histologically by the presence of
haemozoin-containing phagocytes, several immunoblasts
(blast T cells) in the peri-arteriolar lymphatic sheath area
and B-cell activation (centroblasts) in germinal centres.
Technical difficulties associated with splenocyte isolation on
d13 precluded the analyses of the cytokine expression pro-
files at this important time point. At this stage, the spleen
showed evidence of strong and disorganized B cell activa-
tion and proliferation, and phagocytes were heavily laden
with haemozoin.
Splenocytes of Saimiri monkeys on d28 (15 days after
the start of anti-malarial treatment) showed a very differ-
ent response pattern in relation to early, acute infection
(d7). Cells incubated for six hours without any antigenic
stimulation showed increased baseline expression of IL2,
IL6, IL10, IL12, and TNFα, but not IFNγ. Therefore,
15 days after start of treatment, splenocytes remainedactivated. In addition, a relevant change in the profile of
cytokine expression was observed in relation to the acute
phase of infection, with IL10 being switched on and IFNγ
off. Strikingly, contact with the parasite in vitro, instead of
stimulating a further burst in cytokine expression, actually
shut down the splenocyte response for all cytokines. One
possible explanation for this phenomenon is that cells
strongly stimulated in vivo by infection are activated, pro-
liferate and differentiate to a state at which they were no
longer able to be restimulated [41]. Instead, the shut down
in the response suggests that active mechanisms of im-
munosuppression, such as antigen-induced anergy [42] or
induction of apoptosis [43,44], are actually taking place.
It has indeed been shown that malaria parasites have
mitogenic properties and injection of polyclonal B cell acti-
vators prior to immunization of normal mice may suppress
the response to antigens [45-47]. This phenomenon may be
one of the factors involved in the genesis of immunosup-
pression associated with human and experimental malarias
[44,45]. The histological findings support this line of
Figure 4 Changes in spleen histology during Plasmodium falciparum infection. 4A-C: Spleens of non-infected control animals, showing
well-defined limits between the red and white pulps (A), quiescent T-cell zones without immunoblasts (B); a central arteriole is denoted by an asterisk)
and mostly resting B-cell follicles (C). Clusters of weakly stained cells, suggestive of macrophages, were observed (A, C, arrows). D-F: At d7 of infection,
haemozoin was observed throughout an engorged red pulp (D, asterisk). Follicles showed numerous phagocytosis centers (D, arrows). Limits between
the red and white pulps were blurred and follicles presented light-stained nuclei cells surrounded by small lymphocytes (E), and the B-cell follicles
showed penetration by RBCs (E, asterisks). Large cells with weakly stained nuclei suggestive of centroblasts were widespread (central darker area of the
image), and mitosis (black arrows) and apoptosis foci (red arrows) were abundant (F). All sections were stained with Lennert’s Giemsa.
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Figure 5 Changes in spleen histology during Plasmodium falciparum infection. 5A-D: At d13 of infection (just before chloroquine
treatment), the red pulp was further enlarged in relation to controls and d7 of infection and laden with haemozoin (A, asterisk). The follicles were
also enlarged and limits between the red and white pulp were blurred (A, arrow). Phagocytes were heavily laden with pigment and strings of
cells suggestive of plasmacytogenesis cords were observed near the T-cell zone (B). Follicles showed penetrating RBCs and limits between red
and white pulp were blurred (C). Follicles were interspersed with cells of different morphology, showing phagocytes with malaria pigment,
centroblasts and mainly small lymphocytes in the periphery (D). E, F: At d28 (15 days after start of chloroquine treatment), the red pulp
phagocytes were heavily laden with malaria pigment (E, F). The distribution of haemozoin-containing phagocytes was better defined in relation
to d13, with individual cells containing more compacted, less granulous pigment (E, F). The follicles were further enlarged in relation to d13, with
large follicles touching each other with little red pulp in between (E) and showed mostly activated cells (F). All sections were stained with
Lennert’s Giemsa.
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tion to uninfected controls, with extensive predominance
of activated cells over small lymphocytes. Importantly, mac-
rophages heavily laden with haemozoin persisted even
15 days after treatment. Haemozoin has been shown to
suppress immune responses in vitro [48-50], therefore the
inability of the spleen to eliminate it is probably responsible
for the persistent cellular activation long after treatment
and a key factor involved in the malaria-driven malfunction
of the immune system.
Persistent activation was also evident in the B cell com-
partment. Follicle disarray with disturbance of germinal
centre architecture responses in Saimiri was similar to the
findings reported in human [34] and murine (Plasmodium
berghei, Plasmodium chabaudi) malarias [19,51] and
therefore it appears to be an universal feature of malaria
infections. Follicles remained enlarged and composed
mainly by activated B cells 15 days after the start of
chloroquine treatment, which is consistent with a status of
spontaneous polyclonal B cell activation previously dem-
onstrated both in rodent and human malaria [52-54].
Altogether, these observations may have fundamental
importance for the understanding of the mechanisms of
immunity to malaria and for vaccine development. Indeed,
a potential vaccine may fail in the field due to persistently
compromised immune systems of malaria-exposed indi-
viduals rather than to any intrinsic flaws in its immuno-
genic and protective features.
Conclusion
The present study shows that quantitative real-time PCR
using primers designed for Saimiri and Aotus cytokines can
be valuable tools in immunological research using these pri-
mate models, particularly in malaria vaccine and pathogen-
esis studies. In addition, the patterns of cytokine expression
during P. falciparum blood stage growth and after anti-
malarial treatment in Saimiri indicates that blood stage in-
fection induces an early Th1-skewed immune response, that
splenocytes of infection-primed animals remain activated
after cure probably due to haemozoin persistence, and that
antigen stimulation impairs rather than boosts cytokine re-
sponse in the spleen.
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